Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baihe Gujin tablets for cough due to bronchiectasis
ChiCTR2200059676Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Gujin Granule in bronchiectasis and cough (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Cough VAS Score. Planned start May 2022; status: not yet recruiting.
02
Drugs
Gujin Granule
03
Conditions
bronchiectasiscough
Beyond the preview
Go deeper on ChiCTR2200059676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059676.